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service evaluation in 3 regional HSCTcentres (84 participants
in 8 professional groups).
Phase two:ALLINEX development & beta testing. Web-site
content was designed by health & psychosocial care
specialists in response to the outcomes of Phase I. Local &
national information resources were used to provide
content. Beta testing in patients (23), HSCT staff (24) & family
doctors (3) drove iterative development culminating in
a ﬁnal design for use in phase three.
Phase three: A randomised pilot study recruited patients
<2.5y post-HSCT with predicted minimum review of 2 clinic
visits within 12 weeks of informed consent. Stratiﬁed ran-
domisation (with/without Graft versus Host Disease) allo-
cated participants to SC or SC plus ALLINEX. Patient reported
outcomes including HADS, SDI-21 & EORTC QLQ-C30 were
collected at baseline & 12w post consent. Patients in the
intervention arm completed questionnaires on Patient
Acceptance & Use of Technology at 6w, ALLINEX feedback &
system usability scale at 12w & had website activity tracked.
All clinic visits were audio-recorded for simple content
analysis & additional contacts logged.
Results: Services evaluation identiﬁed gaps in service (e.g.
limited psychological support), standard services (e.g. open
access to transplant team) & reactive services (e.g.referrals to
psychiatry). Consequently, ALLINEX included information in
5 domains ranging from “everyday living” to “end of life,” an
interactive patient forum & a messaging system for con-
tacting the HSCT team. Beta testing resulted in minor
amendments.
Phase three recruitment was completed September 2012
with a participation rate of 71% & 50/53 patients completing
the study. Analysis is ongoing (due completion December
2012).
Conclusions: Involvement of patients & staff at all stages of
ALLINEX development has resulted in a website that per-
formed well in preliminary testing. Initial analysis indicates
that the site is relevant, accessible & comprehensive. Final
analysis may lead to changes in ALLINEX, guidance training
for patients & staff & further development of the interactive
aspects of the site.
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Objective: Hematopoietic stem cell transplantation (HSCT) is
a potentially curative therapy for malignant and autoim-
mune diseases. As the scope of transplant expands treatment
for more diseases and patient types, quality of life (QOL)
speciﬁcally fatigue, will remain an important measure for
outcome and long term survival in HSCT. Overall QOL is re-
ported to return to baseline or exceeds baseline by one year
while fatigue remains amajor symptom that is long lasting as
far out as 10 years.
Methods: A Pub Med search was completed in 2009 using
mesh terms, HSCT, bone marrow transplant, and quality of
life. This resulted in one hundred and seventy nine articles.
When fatigue was added to the mesh terms the number of
articles dropped to eleven. Highly relevant references were
chosen from articles and books. The National Comprehensive
Cancer Network (NCCN)websitewas also used as a source for
cancer related fatigue.
Results: Long term follow up studies of HSCT patients as far
out as ten years report fatigue as high as 35%. In comparative
trials with healthy controls this has been shown to be
statistically signiﬁcant. Multiple reasons may exist for this
prolonged decrement including chronic graft versus host
disease, preparative regimens, treatment prior to HSCT and
underlying disease. No studies to date have determined the
underlying etiology of long standing fatigue. Small studies
with exercise interventions and cognitive behavioral therapy
show promising results. These types of treatment may have
an impact on patients with fatigue following HSCT.
Conclusion: Multidimensional scales have been used to
measure fatigue in many QOL studies but few to date have
used fatigue speciﬁc scales. Multimodal interventions have
been shown to decrease the loss of aerobic ﬁtness, muscle
strength, and functional performance. Interventions with
exercise in addition to behavioral therapy with objective
physical measures and fatigue measurement scales may be
beneﬁcial in determining the cause of this chronic symptom
in patients post HSCT.
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Background: Evidence is mixed regarding the effects of
hematopoietic cell transplantation (HCT) on changes in
cognitive functioning among adults. Meta-analysis may help
reconcile conﬂicting ﬁndings but has not yet been conducted
with this literature. The current study provides a systematic
review and meta-analysis of cognitive functioning in adults
receiving HCT.
Methods: A search of PubMed, PsycInfo, CINAHL, and
Cochrane Library yielded 732 abstracts, which were inde-
pendently evaluated and selected for inclusion by pairs of
raters. Original studies of neuropsychological functioning in
HCT recipients who were adults at the time of transplant
were included in the systematic review (k¼17). A subset of
studies assessing patients pre- and post-transplant and
providing adequate data to calculate effect sizes was
included in the meta-analysis (k¼11).
Results: The systematic review found consensus that
a subset of patients experience cognitive impairment prior to
HCT. Evidence was conﬂicting about whether cognitive
functioning improved, declined, or remained stable at
follow-up. Meta-analytic ﬁndings of 404 patients indicated
no signiﬁcant changes in cognitive functioning pre- to post-
HCT (ps>.05). Age, time since transplant, and total body
irradiation were not associated with changes in cognitive
functioning. Patients who received autologous transplants
were more likely to demonstrate improvements in attention
(p¼.004), however.
Conclusions: Results of the current study suggest that on
average, patients who are experiencing cognitive difﬁculties
prior to HCT are unlikely to demonstrate signiﬁcant improve-
ment post-transplant, with the exception of improved atten-
tion in autologous HCT recipients. The failure of HCT patients
to demonstrate improvements over repeated tests may itself
be a sign of a deﬁcit, as improvement due to test familiarity
would be expected. Patients reporting cognitive difﬁculties
that interfere with daily functioning should be referred to
a neuropsychologist for evaluation and management.205
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Background: Quality of life is increasingly recognized as one
of patients’ primary concerns and an important clinical
endpoint of hematopoietic cell transplant (HCT). Although
a growing body of research has examined change in quality
of life during the transplant process, the extent to which
these data have been incorporated into patient education is
unclear. The goal of the current study was to examine
education regarding post-HCT quality of life from the
patient's perspective.
Methods:Men andwomenwho had received allogeneic HCT
two to four years previously participated in one of four
qualitative focus groups based on a semi-structured inter-
view guide. Participants were asked to recall what they had
been told about post-HCT quality of life as they were
deciding to undergo the transplant, how their current quality
of life differed from what they expected, and how to best
educate future HCT recipients about quality of life. Verbatimtranscripts were coded for a priori and emergent themes
using content analysis.
Results: A total of 24 patients participated (54% female,
mean age 51, range 23-73). Regarding patient education,
most participants noted that they had been told about
potential side effects of HCT and behavioral and dietary
restrictions, but little about quality of life. Many reported
actively trying to avoid information about HCT pre-trans-
plant and instead focused on surviving the procedure.
Participants often reported that their post-HCT quality of life
ﬂuctuated, which was contrary to their expectations
regarding sustained improvement. Participants widely
agreed that patient education regarding quality of life should
occur throughout the transplant process. They emphasized
that the ability to control the amount of information was
important, as was hearing about quality of life from other
patients.
Conclusions: These data suggest that patient education
regarding post-HCT quality of life could be improved.
Educational materials that are tailored to patients’ informa-
tion preferences, can be used throughout transplant and
survivorship, and feature other HCT recipients are preferred.206
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Purpose/Hypothesis: To examine the impact of an in-patient
exercise program of participants undergoing hematopoietic
stem cell transplant (HSCT) on functional capacity, and to
compare the relationship between exercise compliance and
incidence of exercise-related adverse events. The goals are
1) to examine the feasibility of tracking outcomes of an
exercise program in patients undergoing HSCT on their
functional capacity, and 2) to examine the association
between exercise compliance and exercise-related effects in
patients with severe pancytopeniawithin this patient cohort.
Materials/Methods: 30 adult participants were recruited
during their inpatient hospital stay. Participants completed
the short form Physical Activity Questionnaire (PAQ), 6-
minute walk test and 5-times-repeated-sit-to-stand test at
time of transplant and 12-14 days post-transplant. Partici-
pants instructed in a multimodal intervention to include
aerobic (walking or stationary bike), resistance (resistance
bands), and active range of motion exercises. Exercise
compliance was measured by the patient's exercise log.
Incidence of hemorrhagic events and platelet levels were
collected. This research consisted of a one group pre-test/
post-test study design with consecutive sampling over an
estimated nine month span (recruitment to be ﬁnished by
October 2012). Descriptive statistics will be used to describe
functional capacity trends from pre and post-test measure-
ments, to examine patient's functional capacity from start
and end of study. This study will be utilizing a post hoc
analysis to further investigate compliance and differences on
functional capacity measures by subgroups. Will also deter-
mine the relationship of the incidence of exercise-related
pancytopenia events over 14 days and percent exercise
compliance rate, controlling for confounding factors.
Results: We anticipate that participants performing the
prescribed exercise program will have improved functional
capacity. We expect no difference with higher exercise
compliant participants in incidence of hemorrhagic events as
